Status:
RECRUITING
Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Brief Summary
Entero-MRI is indicated in Crohn's disease as part of the initial work-up or follow-up (to assess response to treatment, complications). The protocol for carrying out the examination complies with pre...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient with MR enterography examination for follow-up or suspected Crohn's disease
- No Exclusion Criteria.
Exclusion
Key Trial Info
Start Date :
July 23 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 23 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06526234
Start Date
July 23 2024
End Date
July 23 2025
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Vandœuvre-lès-Nancy, CHRU de Nancy, France, 54511